Skip to content

Étiquette : aortic stenosis

Cardiawave présentera les résultats de suivi à 30 jours de son étude pivot « Valvosoft® Pivotal Study » pour le traitement de la sténose valvulaire aortique sévère symptomatique à la 73ème Conférence annuelle de l’ACC – 6-8 avril 2024

By bertrand

05/04/2024 Cardiawave présentera les résultats de suivi à 30 jours de son étude pivot « Valvosoft® Pivotal Study » pour le traitement de la sténose valvulaire aortique sévère symptomatique à la 73ème Conférence annuelle de l’ACC – 6-8 avril 2024 DOWNLOAD THE PRESS RELEASE > << Press Release

Cardiawave featured in a recent article by Cardiovascular Business !

By bertrand

Cardiawave featured in a recent article by Cardiovascular Business ! December 14th 2023 🚀 Cardiawave was featured in a recent article by Cardiovascular Business, highlighting the potential of our non-invasive ultrasound therapy device for the treatment of aortic stenosis to become part of current and future medical solutions ! Thanks to Cardiovascular Business for this … Continued

Cardiawave featured in ESC TV Today!

By bertrand

Cardiawave featured in ESC TV Today!  November 27th 2023 🔬Cardiawave is thrilled to share ESC TV Today’s video spotlighting its recently published clinical study results in The Lancet! The 40 patients suffering from severe symptomatic aortic stenosis treated by the medtech innovative Non-Invasive Ultrasound Therapy (NIUT) experienced an improvement in their quality of life.Our team’s … Continued

Cardiawave’s First-in-Human clinical studies results published in The Lancet!

By bertrand

Cardiawave’s First-in-Human clinical studies results published in The Lancet! November 17th 2023 📢 Cardiawave is proud to announce the publication of its First-In-Human (FIH) clinical studies results with 40 patients suffering from aortic stenosis treated with its innovative Non-Invasive Ultrasound Therapy (NIUT) device in The Lancet journal! 🚀 📖 The Lancet is a prestigious medical journal, … Continued